|
Preventing opioid overdose deaths with take-home naloxone |
harm reduction | overdose |
|
Preventing overdose deaths in Europe (Perspectives on drugs) |
best practice | death | drugs | harm reduction | injecting | injection | opioid injectors | overdose | stimulant injectors |
|
Review and synthesis of scientific literature on drug-related non-fatal emergencies |
health effects | overdose |
|
European Drug Report 2015: Trends and Developments |
alcohol | amphetamines | cannabis | chemistry | co-morbidity | cocaine | consumption rooms | crime | death | demand | drug-law offences | environmental indicators | epidemiology | evaluation | gender | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | methodology | new psychoactive substances (NPS) | older people | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | Reitox | research | seizures | social exclusion | social reintegration | spice | statistics | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends | young people |
|
2009 Annual report on the state of the drugs problem in Europe |
amphetamines | cannabis | co-morbidity | cocaine | demand | drug-law offences | emcdda | epidemiology | evaluation | hallucinogens | harm reduction | health effects | heroin | HIV | infectious diseases | injecting | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | research | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends |
|
European Drug Report 2013: Trends and developments |
amphetamines | cannabis | cocaine | consumption rooms | crime | death | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | prevalence | prevention | prison | seizures | social reintegration | statistics | substitution treatment | supply | treatment | trends |
|
European Drug Report 2014: Trends and developments |
amphetamines | cannabis | cocaine | crime | death | demand | drug-law offences | harm reduction | health effects | heroin | infectious diseases | injecting | key indicators | markets | new psychoactive substances (NPS) | opioids | overdose | policy | prevalence | prevention | price | prison | problem drug use | recreational drugs | seizures | statistics | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends | young people |
|
Preventing fatal overdoses: a systematic review of the effectiveness of take-home naloxone |
best practice | death | harm reduction | health effects | heroin | opioid injectors | opioid users | opioids | overdose | treatment |
|
2010 Annual report on the state of the drugs problem in Europe |
amphetamines | cannabis | co-morbidity | cocaine | crime | death | demand | drug-law offences | emcdda | epidemiology | gender | hallucinogens | health effects | heroin | HIV | infectious diseases | injecting | key indicators | law | markets | new psychoactive substances (NPS) | opioids | overdose | policy | polydrug use | prevalence | prevention | price | prison | problem drug use | public expenditure | purity | recreational drugs | research | seizures | social exclusion | social reintegration | spice | strategies | substitution treatment | supply | synthetic stimulants | trafficking | treatment | trends |
|
Emergency health consequences of cocaine use in Europe. A review of the monitoring of drug-related acute emergencies in 30 European countries |
cocaine | death | epidemiology | health effects | key indicators | new psychoactive substances (NPS) | overdose | prevalence | recreational drugs |
Belgium
Bulgaria
